Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP864665.RAprGFst1EFPCTxWgtphuxYTZySrzEU3xGqDYn1lCL62s130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP864665.RAprGFst1EFPCTxWgtphuxYTZySrzEU3xGqDYn1lCL62s130_assertion type Assertion NP864665.RAprGFst1EFPCTxWgtphuxYTZySrzEU3xGqDYn1lCL62s130_head.
- NP864665.RAprGFst1EFPCTxWgtphuxYTZySrzEU3xGqDYn1lCL62s130_assertion description "[According to the CAO-/ARO-/AIO-94 trial of the German Rectal Cancer Study Group, pre-operative 5-fluorouracil (5-FU)-based long-term chemoradiotherapy (CT/RT) is recommended for patients with rectal cancer UICC stage II/III.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP864665.RAprGFst1EFPCTxWgtphuxYTZySrzEU3xGqDYn1lCL62s130_provenance.
- NP864665.RAprGFst1EFPCTxWgtphuxYTZySrzEU3xGqDYn1lCL62s130_assertion evidence source_evidence_literature NP864665.RAprGFst1EFPCTxWgtphuxYTZySrzEU3xGqDYn1lCL62s130_provenance.
- NP864665.RAprGFst1EFPCTxWgtphuxYTZySrzEU3xGqDYn1lCL62s130_assertion SIO_000772 18722050 NP864665.RAprGFst1EFPCTxWgtphuxYTZySrzEU3xGqDYn1lCL62s130_provenance.
- NP864665.RAprGFst1EFPCTxWgtphuxYTZySrzEU3xGqDYn1lCL62s130_assertion wasDerivedFrom befree-20150227 NP864665.RAprGFst1EFPCTxWgtphuxYTZySrzEU3xGqDYn1lCL62s130_provenance.
- NP864665.RAprGFst1EFPCTxWgtphuxYTZySrzEU3xGqDYn1lCL62s130_assertion wasGeneratedBy ECO_0000203 NP864665.RAprGFst1EFPCTxWgtphuxYTZySrzEU3xGqDYn1lCL62s130_provenance.